Advancing Respiratory Medicine

The MediPines AGM100® provides fast, accurate, and non-invasive assessments of cardiorespiratory status to improve treatment and diagnostic decisions.

How the AGM100 Works

Measurement in under 90 seconds

See how it works

Clinicians use AGM100 measurements to

  • Immediately identify respiratory impairment at the point of care
  • Help guide diagnosis and treatment decisions from chronic to acute cases
  • Confirm treatment effectiveness with high degree of objectivity
  • Verify worsening/improving cardiorespiratory conditions
  • Manage patients for positive health outcomes

Award winning medical device, trusted by doctors and patients

AGM100 selected by WHO

Medical Innovation

who-cover-web

“Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured”

- WH0 Assistant Director General

 

Medical Design Award

AGM100 receives special designationmdea design award

 MediPines AGM100® device has been awarded the prestigious MDEA Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence Awards

Seattle-Childrens
Rush-logo
freemanlogo
advent-health-logo
stevensonmemoriallogo

Improve Patient Outcomes


Non-Invasive
Achieve over 90% patient compliance with our breathing circuit.
High Precision
PaO2 accuracy of over 95% compared to traditional ABG.
Single Operator
No labs, blood draw or complex set up. No calibration required.
Multi-parameter
In less than 2 minutes, we provide 12 cardiopulmonary diagnostic parameters

Use Cases

Improve diagnostic decisions across the continuum of care. From the emergency room to out-patient clinics, our device has helped patients receive faster, more accurate diagnosis.

Global Respiratory Disease

We are the market leader in non-invasive, rapid assessment of pulmonary gas exchange.

COVID-19: 676 million people
Pneumonia: 450 million people annually
Asthma: 350 million people
COPD: 200 million people

News and Updates

Our Latest Publications

Read about the latest publications and learn the science behind the AGM100.